Current Report Filing (8-k)
May 31 2019 - 4:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 31, 2019
QUORUM HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-37550
|
|
47-4725208
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
file number)
|
|
(IRS Employer
Identification No.)
|
1573 Mallory Lane
Brentwood, Tennessee 37027
(Address of principal executive offices) (Zip Code)
Registrants Telephone Number, Including Area Code: (615)
221-1400
Not Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17
CFR
240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, $0.0001 par value per share
|
|
QHC
|
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
Quorum Health Corporation (the Company) held its 2019 Annual Meeting of Stockholders (the Annual Meeting) on
May 31, 2019. The following describes the matters that were submitted to the vote of the stockholders of the Company at the Annual Meeting and the result of the votes on these matters:
(1) The stockholders elected each of the following persons as directors of the Company for terms that expire at the 2020 annual meeting of the
stockholders of the Company and until his or her successor is elected and qualified, based on the following vote results:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
For
|
|
|
Against
|
|
|
Abstain
|
|
|
Broker Non-Votes
|
|
(a) Terry Allison Rappuhn
|
|
|
17,143,011
|
|
|
|
648,919
|
|
|
|
3,655
|
|
|
|
7,232,627
|
|
(b) Robert H. Fish
|
|
|
16,770,712
|
|
|
|
1,021,167
|
|
|
|
3,706
|
|
|
|
7,232,627
|
|
(c) Joseph A. Hastings, D.M.D.
|
|
|
16,678,702
|
|
|
|
1,113,220
|
|
|
|
3,663
|
|
|
|
7,232,627
|
|
(d) Jon H. Kaplan
|
|
|
17,419,145
|
|
|
|
210,736
|
|
|
|
165,704
|
|
|
|
7,232,627
|
|
(e) Barbara R. Paul, M.D.
|
|
|
17,583,210
|
|
|
|
208,580
|
|
|
|
3,795
|
|
|
|
7,232,627
|
|
(f) William Paul Rutledge
|
|
|
17,418,807
|
|
|
|
211,066
|
|
|
|
165,712
|
|
|
|
7,232,627
|
|
(g) Alice D. Schroeder
|
|
|
17,440,572
|
|
|
|
189,159
|
|
|
|
165,854
|
|
|
|
7,232,627
|
|
(h) R. Lawrence Van Horn, Ph.D.
|
|
|
17,417,463
|
|
|
|
374,453
|
|
|
|
3,669
|
|
|
|
7,232,627
|
|
(2) The stockholders approved the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan, based
on the following vote results:
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
15,707,020
|
|
2,073,555
|
|
15,010
|
|
7,232,627
|
(3) The stockholders approved the Quorum Health Corporation 2018 Restricted Stock Plan, based on the following
vote results:
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
16,382,631
|
|
1,397,614
|
|
15,340
|
|
7,232,627
|
(4) The stockholders approved the
advisory (non-binding) resolution
regarding the compensation of the Companys named executive officers, based on the following vote results:
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
16,393,603
|
|
1,387,939
|
|
14,043
|
|
7,232,627
|
(5) The stockholders ratified the appointment of Deloitte & Touche, LLP as the Companys
independent registered public accounting firm for the year ending December 31, 2019, based on the following vote results:
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
23,992,026
|
|
775,763
|
|
260,423
|
|
0
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
QUORUM HEALTH CORPORATION
(registrant)
|
|
|
By:
|
|
/s/ R. Harold McCard, Jr.
|
|
|
R. Harold McCard, Jr.
|
|
|
Senior Vice President, General Counsel, and
Secretary
|
Date: May 31, 2019
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Apr 2023 to Apr 2024